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SUMMARY
Aquaporins (AQPs) are integral membrane channels responsible for the transport of
water across a cell membrane. Based on reports that AQPs are present and
accumulate in the female reproductive tract late in pregnancy, our aim was to study
the expression of AQP isoforms (AQP1, 2, 3, 5, 8, and 9) at the endof pregnancy in rat
in order to determine if they play a role in parturition. Reverse-transcriptase PCR
revealed that specific Aqp mRNAs were detectable in the myometrium of non-
pregnant and late-pregnancy (Days 18, 20, 21, and 22 of pregnancy) rat uteri.
The expression of Aqp5 mRNA and protein were most pronounced on Days
1821, and were dramatically decreased on Day 22 of pregnancy. In contrast, a
significant increase was found in the level of Aqp5 transcript in whole-blood samples
on the last day of pregnancy. The effect of oxytocin onmyometrialAqp5 expression in
an organ bathwasalso investigated. The level ofAqp5mRNAsignificantly decreased
5min after oxytocin (108M) administration, similarly to its profile on the day of
delivery; this effect was sensitive to the oxytocin antagonist atosiban. The vasopres-
sin analog desmopressin (3.7 108M), on the other hand, did not alter the
expression of Aqp5, but did increased the amount of Aqp2 mRNA, an effect that
was atosiban-resistant. These results lead us to propose that oxytocin selectively
influences the expression of Aqp5 at the end of pregnancy, and may participate in
events that lead to parturition in the rat. The sudden increase of AQP5 in the blood on
the last dayof pregnancymayserveasamarker that indicates the initiationof delivery.
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INTRODUCTION
Water is the major component of cells and tissues, and
water movement across the cell membrane is a fundamen-
tal property of life. It was long assumed that the transport of
water was due to simple diffusion through the lipid bilayer
that encloses cells; this picture changed when the first
water channel, aquaporin (AQP)-1, was identified in human
erythrocytes (Preston et al., 1992). The AQPs are a family
of small (2534 kDa), hydrophobic, integral-membrane,
channel proteins that facilitate the rapid, passivemovement
of water across amembrane. To date, 13 isoforms of AQPs
(AQP0AQP12) have been identified in mammals. In view
of the differences in coding sequence, permeability prop-
erties, and the findings of phylogenetic comparisons,
AQP0AQP10 are sub-divided into two major groups:
classical AQPs and aquaglyceroporins (Agre et al., 2002;
Agre and Kozono, 2003; Zardoya, 2005). Classical AQPs
(AQP0, AQP1, AQP2, AQP4, AQP5, AQP6, andAQP8) are
selective channels that are permeable to water, but not to
small organic or inorganic molecules. Aquaglyceroporins
Abbreviations: AQP, aquaporin; OT, oxytocin.
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(AQP3, AQP7, AQP9, and AQP10) are non-selective chan-
nels that allow the flow of glycerol, urea, and other small
non-electrolytes as well as water. The functions of AQP11
and AQP12, referred to as super-aquaporins, are not clear.
The physiological roles of AQPs have been deduced on
the basis of experiments with Aqp knockout animals and
human diseases, as specific inhibitors are not available
(Skowronski, 2010).
Previous studies have shown that specific AQP isoforms
are expressed in both the male and female reproductive
tissues of the rat and mouse (Jablonski et al., 2003). The
abundance of human endometrium AQP2 in the mid-se-
cretory phaseat the timeof embryo implantation suggested
that this isoform plays a role in uterine receptivity (He
et al., 2006). It has also been postulated that AQPs partici-
pate in fertilization, blastocyst formation, and implantation
(Richard et al., 2003). Multiple aquaporins are expressed
in early-stage human embryos, while AQP3 andAQP7 play
roles in pre-implantation mouse embryo development.
Knockdown of either AQP3 or AQP7 levels by targeted
siRNA injection into 2-cell mouse embryos significantly
inhibited pre-implantation development (Xiong et al.,
2013). Moreover, the expression and distribution of Aqp3
is developmentally regulated from the 8-cell to blastocyst
stage inmouse embryos before and after vitrification (Nong
et al., 2013).
The cellular and sub-cellular localization of amniotic
AQPs indicate that these channels also play distinct roles
inwater and urea transport, cellmigration, cell proliferation,
and apoptosis during amniotic fluid homeostasis and/or
tissue remodeling of amniotic membranes (Kobayashi
and Yasui, 2010). AQP1, 3, 8, 9, and 11, for example,
play crucial roles in the transfer of water across the placen-
ta. Mann et al. (2006) detected a significant increase in
AQP1 expression in the amnions of polyhydramnios indi-
viduals, whereas there were significant decreases inAQP1
and AQP3 in the amnion and chorion of oligohydramnios
individuals. The expression of AQP8 is significantly lower
in the oligohydramnios placenta than in the normal-
pregnancy placenta at term, and the expression of AQP9
mRNA in the fetal membranes is higher in polyhydramnios
individuals (Sha et al., 2011). AQP11 expression has also
been reported in the human amniotic membrane at term
(Prat et al., 2012).
Data concerning the expression of AQPs in the late-
pregnancy uterus and in relation to parturition have not
been established. Consequently, the primary aim of this
study was to examine the expression of AQPs in the late-
pregnancy rat uterus. We additionally hoped to identify
hormonal regulators of AQP expression during pregnancy,
which we predict to be regulated by steroid sex hormones
(Lindsay and Murphy, 2006, 2007). As oxytocin (OT) is one
of the main hormones responsible for pregnant uterine
contractions, we investigated whether or not OT has any
effect on theexpressionofAQPs in late-pregnancy rat uteri.
To assess specificity of action, we also evaluated how
vasopressin, which regulates AQP2 expression in the kid-
ney (Wilson et al., 2013) and differs in sequence fromOTby
only two amino acids, affects uterine Aqp expression.
RESULTS
Reverse-transcriptase PCR investigations revealed that
the mRNAs of the investigated Aqp isoforms (Aqp1, 2, 3, 5,
8, and 9) were detectable in the myometrium of non-
pregnant and late-pregnancy (Days 18, 20, 21, and 22 of
pregnancy) rats. The peak of Aqp1 mRNA expression,
observed on Day 18, decreased towards the end of preg-
nancy (Day 22) (Fig. 1a). Aqp2 and Aqp8 transcripts in-
creased significantly onDay18and remained high until Day
21, but declined to the level in the non-pregnant uteri by
Day 22 (Fig. 1b and e). Aqp5 mRNA was highest on
pregnancy Days 1821, followed by a dramatic decrease
on the last day of pregnancy (Fig. 1d). The abundance of
Aqp3 and Aqp9 mRNA remained lower than those in the
non-pregnant uteri on all days investigated (Fig. 1c and f).
Given the timing of peak transcription, we further
investigated the mRNA and protein expression of Aqp5
in non-pregnant animals as well as periodically throughout
pregnancy (Days 8, 12, 16, 18, 20, 21, and 22). Uterine
Figure 1. Reverse-transcriptasePCRanalysisofAqp1 (a),2 (b),3 (c),
5 (d), 8 (e), and 9 (f) expression in late-pregnancy rat uteri (n¼6 per
day). Changes in expression ofAqp5mRNAweremost extensive, with
a dramatic decrease on the day of birth. ns P>0.05, P<0.05,
P<0.01, P<0.001 as compared with the control, non-pregnant
uterus (NP).RQ, relative quantityofmRNAcompared toActb. Eachbar
denotes the mean standard deviation.
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Aqp5 mRNA abundance peaked on Day 18, while protein
levels peaked on Day 20 (Fig. 2). In contrast, Aqp5 mRNA
and protein expression in the blood did not undergo signifi-
cant changes until the final day of pregnancy (Fig 3).
Invitro pre-treatment ofmyometriumcross-sectionswith
OT (striped column) caused an increase in uterine Aqp2
expression on Day 18, but the OT antagonist atosiban
(gridded column) prevented this effect (Fig. 4). Aqp5
mRNA levels significantly decreased (striped columns)
relative to the control uterus within 5min after OTadminis-
tration (Fig. 5), but this difference gradually declined such
that no significant differencewas found between themRNA
levels after 20min. In the presence of atosiban, Aqp5
mRNA abundance (dotted column) was still lower than
the control, but it was significantly higher than the OT-
treated samples (Fig. 5). Again, no differences were ob-
served in theAqp5mRNA levels as compared with the non-
treated sample 10 or 20min after atosiban treatment.
Desmopressin, an analog of vasopressin that differs
from OT by only two amino acids, increased Aqp2 mRNA
levels on pregnancy Day 18 (Fig. 6a). This effect was
antagonized by atosiban (Fig. 6a, gridded columns). In
contrast, the level of Aqp5mRNA did not change following
desmopressin treatment (Fig. 6b).
DISCUSSION
The AQPs are utilized by a wide variety of cells in organs
such as the kidney, lung, pancreas, brain, gastrointestinal
tract, eye, ear, muscles, uterus, and testis. For example,
in the non-pregnant uterus, Aqp5 expression increased in
the apical plasma membrane of luminal epithelial cells in
response to progesterone, providing a mechanism for the
Figure 2. Reverse-transcriptase PCR and Western blot analysis of
Aqp5 on different days of pregnancy (n¼6 per day). Abundance of
Aqp5mRNA (a) and AQP5 protein (b) was significantly decreased on
the day of birth. ns P>0.05, P<0.05, P<0.01, P<0.001 as
compared with the control, non-pregnant uterus (NP). Each bar
denotes the mean standard error.
Figure 3. Reverse-transcriptase PCR (a) and Western blot analysis
(b) of Aqp5 expression in whole blood (n¼6 per day). Expression
increased significantly on the day of birth. ns P>0.05, P<0.01,
P<0.001 as compared with data on the previous day. Each bar
denotes the mean standard deviation.
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reabsorption of luminal fluid (Lindsay and Murphy, 2006).
Aqp5 is also expressed in a distinct uterine cell type during
the peri-implantation period, when the organ displays
edema and hyperemia (Richard et al., 2003). Our study
demonstrated the presence of Aqp1, 2, 3, 5, 8, and 9 in the
late-pregnancy rat uterus, with a prevalent accumulation of
the Aqp5 subtype near parturition. We detected Aqp5
transcript and protein, both of which were dramatically
down-regulated on the last day of pregnancy. In the blood
of late-pregnancy rats, however, the levels of detectable of
Aqp5 mRNA and protein exhibited a reciprocal pattern
relative to that in the late-pregnancy uterus. Although,
Figure 4. Changes in the expression of Aqp2 mRNA on Day 18 of
pregnancy after oxytocin (OT) and atosiban (A) administration, in vitro
(n¼6per treatment).OT treatment increased the level ofAqp2mRNA,
but this effect was blocked by atosiban pre-treatment. ns P>0.05,
P<0.001 as compared with the 18-day pregnant uterus (18 days).
Figure 5. Changes in the expression ofAqp5mRNA5, 10, and 20min
after pre-treatment with oxytocin (OT) and atosiban (A), in vitro (n¼6
per time point). ns P>0.05, P<0.05, P<0.01, P<0.001 com-
pared to the 18-day pregnant uterus (18 days). nsP>0.05, þP<0.05,
þþP<0.01, as compared between different treatments at the same
time points.
Figure 6. Changes in the expression of Aqp2 (a) and Aqp5 (b) mRNA
after pre-treatment with desmopressin (D) and atosiban (A), in vitro
(n¼6 per time point). The expressions of Aqp2 increased, but that
of Aqp5 mRNA was unchanged after desmopressin administration.
ns P>0.05, P<0.05, P<0.001 as compared with the 18-day
pregnant uterus (18 days).
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we currently have no explanation for this phenomenon,
the characteristic increase in Aqp5 expression in the
blood on the last day of pregnancy provides a valuable
diagnostic marker for predicting the time of delivery.
Such an application is consistent with the clinical use
of a number of proteins (ADAM-12, activin-A, PAPP-A,
inflammatory cytokines, and etcetera) to detect ectopic
pregnancy and pre-term birth by means of routine blood
tests (Rausch and Barnhart, 2012; Bastek and Elovitz,
2013).
Sexual hormones (progesterone and estrogen) regulate
the expression ofAQPs (Kimet al., 2009; Ji et al., 2013; Zou
et al., 2013), while the anti-diuretic effect of vasopressin
regulates theexpressionofAQP2 (Marples et al., 1998).OT
differs from vasopressin in only two amino acids. Both form
a cyclic structure via a disulfide linkage between the cys-
teines in positions 1 and 6 (Terashima et al., 1999). OT is
one of the main uterine-contraction-regulating hormones
in late pregnancy. Near the time of parturition, there is a
significant increase in OTmRNA synthesis, accompanied
by an increase in the local concentration of OT peptide
(Mitchell et al., 1997). OT stimulates its own receptor, but
also cross-reacts with the vasopressin V1a receptor (Aker-
lund et al., 1999). OT is also known to possess anti-diuretic
properties, and the use of OT to induce labor is associated
with water retention and hyponatremia (Li et al., 2008). By
analogy, then it is not surprising that vasopressin can
influence uterine function via its V1a receptors and, to
some extent, OT receptors. These similarities between
OT and vasopressin suggest that OT should influence the
function of AQPs in the pregnant uterus.
To test the possibility that OT directly affects AQP
function during pregnancy, we investigated the myometrial
expression of Aqp5 and Aqp2 mRNA after OT treatment
and in the presence of the OT antagonist atosiban. Our in
vitro studies were carried out on Day 18 of pregnancy
because the expressions of Aqp5 and Aqp2 mRNAs
weremost pronounced at this time.OT treatment increased
Aqp2mRNA levels in the uterus, which is similar to effects
of OT in the kidney (Li et al., 2008; Cheng et al., 2009). OT
treatment also specifically reduced the expression of Aqp5
mRNA in the pregnancy-Day-18 uterus through its own
receptors since the OT receptor antagonist atosiban inhib-
ited the effects of OTon the expressions of Aqp5 and Aqp2
mRNA. In contrast, desmopressin, a synthetic analog of
vasopressin, did not influence the expression of Aqp5
mRNA, but did increase Apq2 mRNA in the uterus. This
effect was atosiban-sensitive, whichmeans that the uterine
effect of desmopressin is mediated mainly through OT
receptors. Although, atosiban also exerts an antagonist
effect on the V2 receptor, this receptor is not expressed in
the myometrium (Manning et al., 1995).
In summary, our experiments have furnished basic
information about the dynamic expression of Aqps in the
late-pregnancy uterus. In light of our results, we presume
thatAQP5, regulatedbyOT,mayplaya role in the regulation
of delivery. Furthermore, the detection of this protein in
the blood may be of diagnostic value as a predictor of
parturition timing.
MATERIALS AND METHODS
Housing and Handling of the Animals
Animals were treated in accordance with the European
Communities Council Directives (86/609/ECC) and the
Hungarian Act for the Protection of Animals in Research
(XXVIII.tv.32.Ï). All experiments involving animal subjects
were carried out with the approval of the Hungarian Ethical
Committee for Animal Research (registration number:
IV/198/2013). SpragueDawley rats (Charles-River Labo-
ratories, Budapest, Hungary) were kept at 22 38C in
a relative humidity of 3070% with a light/dark cycle of
12/12 hr. The animals were maintained on a standard
rodent pellet diet (Charles-River Laboratories) with tap
water available ad libitum. They were sacrificed by CO2
inhalation.
Mating of the Animals
Mature female (180200 g) and male (240260 g)
SpragueDawley rats were mated in a special cage. A
moveable metal door, controlled by a small electric motor
that was turned on by a timer, separated the rooms for the
male and female animals. Since, rats are usually active at
night, the door was opened before dawn. Within 45 hr
after a possible mating, vaginal smears were taken from
the female rats to search for sperm using a microscope at
a 1,200 magnification. When sperm were found or if a
smear was not possible because of an existing vaginal
sperm plug, the female rats were separated andmarked as
first-day pregnant animals.
Reverse-transcriptase-PCR Studies
Tissue isolation Rats (250300 g) were anesthetized
with sodium pentobarbital (1 g/kg, intra-peritoneal). Uterine
tissues from pregnant animals (tissue between two implan-
tations sites) and non-pregnant uteri were rapidly removed
and placed inRNAlater Solution (Sigma-Aldrich, Budapest,
Hungary). The tissues were frozen in liquid nitrogen and
then stored at 708C until the extraction of total RNA.
Blood collection On selected days of pregnancy
(Days 18, 20, 21, and 22), rats were anesthetized
with isoflurane, and blood samples were taken by cardiac
puncture, collected in RNAprotect1 Animal Blood Tubes
(Qiagen, Biomarker Kft., Budapest, Hungary), and stored
at 208C.
Total RNA preparation from tissue Total cellular RNA
was isolated by extraction with guanidinium thiocyanate/
acidphenol/chloroform according to the procedure of
Chomczynski and Sacchi (1987). After precipitation with
isopropanol, the RNA was washed with 75% ethanol, and
then resuspended in diethyl pyrocarbonate-treated water.
Total RNA was isolated from 500ml of whole rat blood
through use of the RNeasy1 Protect Animal Blood Kit
(Qiagen, Biomarker Kft.).
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RNA purity was assessed at an optical density of 260/
280 nm with a BioSpec Nano (Shimadzu, Simkon Kft.,
Budapest, Hungary); all samples exhibited an absorbance
ratio in the range 1.62.0. RNA quality and integrity were
assessed by agarose gel electrophoresis.
Real-time quantitative reverse-transcriptase PCR
Reverse transcription and amplification of the PCR prod-
uctswasperformedusing theTaqManRNA-to-CT
TM1-Step
Kit (Life Technologies, Budapest, Hungary) and an ABI
StepOne Real-Time cycler. Reverse-transcriptase PCR
amplifications were performed as follows: 488C for
15min and 958C for 10min, followed by 40 cycles at
958C for 15 sec and 608C for 1min. The generation of
specific PCR products was confirmed by melting curve
analysis. Table 1 contains the assay IDs for the primers
used. The amplification of b-actin (Actb) served as an
internal control. All samples were run in triplicate. The
fluorescence intensities of the probes were plotted against
PCR cycle number. The amplification cycle displaying the
first significant increase of the fluorescence signal was
defined as the threshold cycle (CT).
Western Blot Analysis
Twenty micrograms of sample protein per well were
subjected to electrophoresis on 412% NuPAGE BisTris
Gel in XCell SureLock Mini-Cell Units (Life Technologies).
Proteins were transferred from gels to nitrocellulose mem-
branes using the iBlot Gel Transfer System (Life Technolo-
gies). The blotswere incubated on a shaker with anti-AQP5
and anti-b-actin polyclonal antibodies (SantaCruzBiotech-
nology, Inc., Dallas, TX, 1:200) in blocking buffer. Antibody
bindingwasdetectedwith theWesternBreezeChromogen-
ic Western blot immundetection kit (Life Technologies).
Images were captured with the EDAS290 imaging system
(Csertex Ltd., Budapest, Hungary), and the optical density
of each immunoreactive band was determined with
Kodak 1D Images analysis software. Optical densities
were calculated as arbitrary units after local area back-
ground subtraction.
In Vitro Study
Uteri were removed from rats on Day 18 of pregnancy.
Muscle rings 5-mm long were sliced from the uterine horns
andmounted vertically in an organ bath containing 10ml de
Jongh solution (137mM NaCl, 3mM KCl, 1mM CaCl2,
1mM MgCl2, 12mM NaHCO3, 4mM NaH2PO4, and
6mM glucose, pH 7.4). This organ bath was maintained
at 378C with carbogen (95%O2, 5% CO2) bubbled through
it. After mounting, the ringswere equilibrated for about 1 hr,
with a solution change every 15min, before experiments
were undertaken. Uterine sampleswere incubated with OT
(1010M), desmopressin (3.7 108M), and atosiban
(106M). Samples were collected after 5, 10, and 20min
for reverse-transcriptase-PCR analysis.
Statistical Analyses
All experiments were carried out on at least six animals,
repeated three times. All curve fittings, data calculations,
and statistical analyses were performed with Prism 5.0
software (GraphPadSoftware, Inc.,SanDiego,CA).Group
comparisons were made by one-way ANOVA tests with the
Tukey’s post-tests.
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